Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 18, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Aug 18, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 1, 2025 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| May 1, 2025 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| May 1, 2025 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| May 1, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Oct 31, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 31, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 31, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 9, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 9, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 10, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 25, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Apr 3, 2024 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Apr 3, 2024 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Apr 3, 2024 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Mar 18, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 18, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 18, 2023 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 18, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 15, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; muscle relaxants; anaesthetics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical preparations acting on the central nervous system; biological preparations for medical purposes being bacterial and bacteriological preparations; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain
Classification
International Classes
005